Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Effect of dose tapering policy on the prescription of advanced therapy for rheumatoid arthritis: a retrospective analysis of clinical and cost outcomes in Taiwan
Ko-Jen Li
,
Chao-Hsiun Tang
,
Chia-Li Chang
,
Han-Fang Liao
,
Pei-Jung Yen
, and
Wen-Yi Shau
Journal of Comparative Effectiveness Research
30 Jul 2026
Systematic review and network meta-analysis of the efficacy, safety and tolerability of xanomeline plus trospium chloride compared with eight oral antipsychotics for the acute treatment of schizophrenia
Conor Hickey
,
Matthew F Sidovar
,
Andrea Garcia
,
Ken Kramer
,
Jen-Yu Amy Chang
,
Katrin Kupas
,
Vyshnavi Telukuntla
,
Jake Horgan
,
Haris Jameel
,
Tracy Westley
,
Kristin K Gillard
, and
Andrew J Cutler
Journal of Comparative Effectiveness Research
30 Jul 2026
An attendee's guide to ISPE 2026: The sessions, themes, and conversations not to miss in Milan
The Evidence Base
30 Jul 2026
Examining the affect of global drug pricing policies on US patient access and pharmaceutical innovation
The Evidence Base
29 Jul 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
30 Jul 2026
An attendee's guide to ISPE 2026: The sessions, themes, and conversations not to miss in Milan
29 Jul 2026
Designing trustworthy RWE: How policy, data infrastructure, and AI shape real‑world impact
27 Jul 2026
Critical Path Institute expands rare disease data platform through Across Healthcare partnership
28 Jul 2026
Another JCA initiated as daraxonrasib enters EU HTA process alongside EMA phased review
24 Jul 2026
ISPOR white paper recommends coordinated evidence generation across European healthcare decision-making
24 Jul 2026
Flatiron Health brings Scottish oncology data into global real-world evidence network
15 Jul 2026
Following the patient journey: How connected data and evolving methods are reshaping real-world evidence
15 Jul 2026
ISPOR Special Task Force introduces IMPACT framework for value-based healthcare implementation
14 Jul 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in June 2026
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
30 Jul 2026
An attendee's guide to ISPE 2026: The sessions, themes, and conversations not to miss in Milan
29 Jul 2026
Examining the affect of global drug pricing policies on US patient access and pharmaceutical innovation
29 Jul 2026
Designing trustworthy RWE: How policy, data infrastructure, and AI shape real‑world impact
28 Jul 2026
Another JCA initiated as daraxonrasib enters EU HTA process alongside EMA phased review
.png)
.png)
